Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Lenz

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Biochemical Pharmacology|May 31, 2021
Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activationPhilipp J Hohensinner, Max Lenz, Patrick Haider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and miceMax Lenz, Manuel Salzmann, Cosmin I Ciotu, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Biochemical Pharmacology|May 31, 2021
Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activationPhilipp J Hohensinner, Max Lenz, Patrick Haider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and miceMax Lenz, Manuel Salzmann, Cosmin I Ciotu, et al.
Pageof 5